Brief: Biotech Capital says unit Bioimpact enters into license agreement with RLS Global

RLS Global AB

05/05/2017 24:40

May 5 (Reuters) - Biotech Capital Ltd  BTC.AX  : 
    * Bioimpact enters into license agreement with RLS Global 
    * Agreement grants Co rights to distribute wound care 
product, within Australia, New Zealand and select countries 
across Asia Pacific region 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nASX2x8gqk 
Further company coverage:  BTC.AX  
 
 ((Bangalore.newsroom@thomsonreuters.com;))